SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
View Top Employees from SignPath Pharma Inc.| Website | http://signpathpharma.com |
| Ticker | SGTH |
| Revenue | $23000 |
| Employees | 10 (7 on RocketReach) |
| Founded | 2006 |
| Address | 9710 Ruskin Cir, Sandy, Utah 84092, US |
| Phone | (215) 538-9996 |
| Fax | (215) 538-1245 |
| Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Manufacturing General, Manufacturing, Science and Engineering, Drug Discovery, Pharmaceutical, Health Care, Therapeutics |
| Web Rank | 16 Million |
| Keywords | Tissue Distribution Filetype:Pdf |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular SignPath Pharma Inc. employee's phone or email?
SignPath Pharma Inc. Questions
The SignPath Pharma Inc. annual revenue was $23000 in 2024.
Pete Childs is the Senior Vice President, Chief Financial Officer of SignPath Pharma Inc..
7 people are employed at SignPath Pharma Inc..
SignPath Pharma Inc. is based in Sandy, Utah.
The NAICS codes for SignPath Pharma Inc. are [325, 32541, 32, 3254].
The SIC codes for SignPath Pharma Inc. are [283, 28].
Top SignPath Pharma Inc. Employees
-
34
-
32
-
View
Timothy Touloukian
Senior Vice President Business Development at SignPath Pharma Inc.
New York, NY, US35+ -
ViewMichelle Comas
Vice President, Regulatory Affairs and Operations at SignPath Pharma Inc.
Salt Lake City, Utah, United States32 -
41
-
21
Related Companies
